Maaike Winkelmeijer
Overview
    Explore the profile of Maaike Winkelmeijer including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              14
            
            
              Citations
              253
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Houttu V, Boulund U, Troelstra M, Csader S, Stols-Goncalves D, Mak A, et al.
  
  
    JHEP Rep
    . 2025 Mar;
          7(3):101289.
    
    PMID: 40051412
  
  
          Background & Aims: Exercise is a key component of lifestyle management in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), but neither its therapeutic effect on the active stage of...
      
2.
        
    
    Aydin O, Meijnikman A, de Jonge P, van Stralen K, Borger H, Okur K, et al.
  
  
    Obes Surg
    . 2024 Aug;
          34(10):3796-3806.
    
    PMID: 39153140
  
  
          Aims/hypothesis: Post-bariatric hypoglycemia (PBH) is caused by postprandial hyperinsulinemia, due to anatomical alterations and changes in post-prandial metabolism after bariatric surgery. The mechanisms underlying the failing regulatory and compensatory systems...
      
3.
        
    
    Attaye I, Witjes J, Koopen A, van der Vossen E, Zwirs D, Wortelboer K, et al.
  
  
    iScience
    . 2024 Aug;
          27(8):110455.
    
    PMID: 39139405
  
  
          This randomized, double-blind, placebo-controlled trial investigated the impact of 14-day  L2-7 supplementation on postprandial glucose levels in 25 White Dutch males with type 2 diabetes (T2D) on stable metformin therapy....
      
4.
        
    
    Scheithauer T, Wortelboer K, Winkelmeijer M, Verdoes X, Aydin O, Acherman Y, et al.
  
  
    Gut Microbes
    . 2024 Jul;
          16(1):2380747.
    
    PMID: 39068518
  
  
          Individuals with type 2 diabetes (T2D) show signs of low-grade inflammation, which is related to the development of insulin resistance and beta-cell dysfunction. However, the underlying triggers remain unknown. The...
      
5.
        
    
    Dzobo K, Cupido A, Mol B, Stiekema L, Versloot M, Winkelmeijer M, et al.
  
  
    Arterioscler Thromb Vasc Biol
    . 2024 Jan;
          44(3):720-740.
    
    PMID: 38269588
  
  
          Background: Oxidized phospholipids play a key role in the atherogenic potential of lipoprotein(a) (Lp[a]); however, Lp(a) is a complex particle that warrants research into additional proinflammatory mediators. We hypothesized that...
      
6.
        
    
    Scheithauer T, Herrema H, Yu H, Bakker G, Winkelmeijer M, Soukhatcheva G, et al.
  
  
    Gut Microbes
    . 2022 Aug;
          14(1):2111951.
    
    PMID: 35984746
  
  
          Hyperglycemia and type 2 diabetes (T2D) are caused by failure of pancreatic beta cells. The role of the gut microbiota in T2D has been studied, but causal links remain enigmatic....
      
7.
        
    
    Scheithauer T, Davids M, Winkelmeijer M, Verdoes X, Aydin O, De Brauw M, et al.
  
  
    Gut Microbes
    . 2022 Feb;
          14(1):2031696.
    
    PMID: 35130127
  
  
          Obesity and type 2 diabetes (T2D) are growing burdens for individuals and the health-care system. Bariatric surgery is an efficient, but drastic treatment to reduce body weight, normalize glucose values,...
      
8.
        
    
    Wortelboer K, Bakker G, Winkelmeijer M, van Riel N, Levin E, Nieuwdorp M, et al.
  
  
    Microbiol Res
    . 2022 Jan;
          257:126972.
    
    PMID: 35091345
  
  
          The intestinal gut microbiota is important for human metabolism and immunity and can be influenced by many host factors. A recently emerged host factor is secreted microRNA (miRNA). Previously, it...
      
9.
        
    
    Koopen A, Witjes J, Wortelboer K, Majait S, Prodan A, Levin E, et al.
  
  
    Gut
    . 2021 Oct;
          71(8):1577-1587.
    
    PMID: 34697034
  
  
          Objective: Although gut dysbiosis is increasingly recognised as a pathophysiological component of metabolic syndrome (MetS), the role and mode of action of specific gut microbes in metabolic health remain elusive....
      
10.
        
    
    Scheithauer T, Bakker G, Winkelmeijer M, Davids M, Nieuwdorp M, van Raalte D, et al.
  
  
    Gut Microbes
    . 2021 Jan;
          13(1):1-14.
    
    PMID: 33475461
  
  
          Intestinal immunoglobulins (Ig) are abundantly secreted antibodies that bind bacteria and bacterial components in the gut. This binding is considered to accelerate bacterial transit time and prevent the interaction of...